MetaCap

Replimune Group (REPL) News

NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

19.07-0.16 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

REPL news summary

We found 14 recent headlines mentioning Replimune Group (REPL): 0 in the past week and 11 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, REPL is down 0.83% at $19.07. The most recent story, "REPL Stock Up 80% in a Month on Tudriqev Launch & Pipeline Progress", was published by Nasdaq on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Replimune Group headlines

Stocks mentioned alongside REPL

Compare REPL